Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 30:257-262, 2007
DOI: 10.2337/dc06-1240
© 2007 by the American Diabetes Association
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansen, T.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, T.
Right arrow Articles by Pedersen, O.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

The BIGTT Test

A novel test for simultaneous measurement of pancreatic ß-cell function, insulin sensitivity, and glucose tolerance

Torben Hansen, MD, PHD1, Thomas Drivsholm, MD, PHD2, Søren A. Urhammer, MD, DMSCI1, Rene T. Palacios, MSCI3, Aage Vølund, MSCI3, Knut Borch-Johnsen, MD, DMSCI1,2 and Oluf Pedersen, MD, DMSCI1

1 Steno Diabetes Center, Copenhagen, Denmark
2 Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark
3 Department of Biostatistics, Novo Nordisk, Copenhagen, Denmark

Address correspondence and reprint requests to Torben Hansen, MD, PhD, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark. E-mail: toha{at}steno.dk


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS--
 CONCLUSIONS--
 References
 
OBJECTIVE—Insulin resistance and impaired ß-cell function are key elements in the pathogenesis of type 2 diabetes. We aimed to develop valid algorithms for estimation of the insulin sensitivity index (SI) and acute insulin response (AIR) derived from simple and cheap physiological measurements that could be used in large-scale metabolic, genetic, and epidemiological studies.

RESEARCH DESIGN AND METHODS—For our purpose, data from an oral glucose tolerance test (OGTT) (18 samples during 240 min) and a tolbutamide-modified intravenous glucose tolerance test (IVGTT) (33 samples during 180 min) from 258 individuals with fasting plasma glucose <7 mmol/l and 2-h plasma glucose <7.8 mmol/l were used for model development and internal validation. Data from an additional 28 individuals were used for external validation. Bergman’s minimal model was used to calculate SI, and the trapezoidal method was used to calculate AIR0–8 min. Multiple linear regression was applied to derive predictive equations of log(SI) and log(AIR0–8 min) using data on sex, BMI, plasma glucose, and serum insulin levels obtained during the OGTT.

RESULTS—We demonstrate that it is possible to obtain estimates of SI (BIGTT-SI) and AIR (BIGTT-AIR) that are highly correlated to IVGTT-derived values of SI (R2 = 0.77) and AIR (R2 = 0.54). In the two validation datasets we obtained similar results.

CONCLUSIONS—Data from OGTTs can provide accurate measures of insulin sensitivity and ß-cell function, which can be used in large scale metabolic, genetic, and epidemiological studies.

Abbreviations: AIR, acute insulin response • HOMA, homeostasis model assessment • IGT, impaired glucose tolerance • IVGTT, intravenous glucose tolerance test • OGTT, oral glucose tolerance test • RCPH, Research Centre for Prevention and Health


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
RESEARCH DESIGN AND METHODS
 RESULTS--
 CONCLUSIONS--
 References
 
The maintenance of normal glucose homeostasis involves the simultaneous and coordinated roles of insulin release from the pancreatic ß-cells and insulin action on peripheral tissues, primarily muscle (1,2). For estimation of whole-body insulin sensitivity, the euglycemic-hyperinsulinemic clamp is considered the "gold standard" (3). The assessment of the insulin sensitivity index (SI) by the minimal model for the intravenous glucose tolerance test (IVGTT) has also been used in numerous studies (4), because the method has the advantage of providing simultaneous information on the SI and acute insulin response (AIR). Both methods are considered to provide exact and, among individuals with normal glucose tolerance, comparable measurements of insulin sensitivity (5). However, because these methods are time consuming and expensive and cannot be performed on the same day as an oral glucose tolerance test (OGTT), neither is suitable for large-scale studies.

In the present study, we examine nondiabetic individuals without impaired glucose tolerance (IGT) to derive equations that are more accurate than those currently available for the SI and the AIR from an OGTT (1,6–12). We have used detailed information from both plasma glucose and serum insulin levels during an extended and frequently sampled OGTT combined with information on anthropometric measures and sex to generate equations and data from a frequently sampled IVGTT performed in the same individuals as reference. The approach is empirical and data driven, with multiple regression statistics being applied to the physiological data obtained.


   RESEARCH DESIGN AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
RESULTS--
 CONCLUSIONS--
 References
 
Individuals for model development and internal validation
OGTT data from 258 individuals with fasting plasma glucose <7.0 mmol/l and 2-h plasma glucose <7.8 mmol/l (nondiabetic without IGT) were used to develop (75% of the data) and validate (25% of the data) models. All participants were from 1 of 60 families as described previously (13). The performance of the model was further examined in 28 individuals with IGT identified in the same 60 families. Before participation in the study, all individuals provided informed consent. The study was approved by the Ethical Committee of Copenhagen and was in accordance with the principles of the Declaration of Helsinki.

OGTT
All individuals underwent a standardized and extended 75-g frequently sampled OGTT. After a 12-h overnight fast, venous blood samples were drawn in triplicate at –10, –5, and 0 min before the OGTT and at 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 140, 160, 180, 210, and 240 min from the start of the glucose load for analysis of plasma glucose and serum insulin levels. The plasma glucose concentration was analyzed by a glucose oxidase method (Granutest; Merck, Darmstadt, Germany). Serum insulin was determined by enzyme-linked immunoadsorbent assay with a narrow specificity excluding des(31,32)-proinsulin and intact proinsulin (DAKO Diagnostics, Ely, U.K.) (14).

IVGTT
All individuals underwent a 33-point tolbutamide-modified, frequently sampled IVGTT (13) within 1 week after the OGTT examination except for a few individuals who underwent an IVGTT within 4 weeks. The SI was calculated using the Bergman MINMOD computer program (15). The glucose-induced serum AIRinsulin 0–8 min was calculated as the incremental areas under the curves from 0 to 8 min.

Individuals for external validation
Twenty-eight nondiabetic individuals without IGT, randomly chosen from participants in a population-based study at the Research Centre for Prevention and Health (RCPH) of 695 individuals born in 1936 (16), were examined by both an OGTT and an IVGTT. An extended 75-g OGTT was performed after a 10-h overnight fast. Blood samples were drawn in duplicate between 7:45 and 10:00 A.M. before the oral glucose load, i.e., at –5 and 0 min and at 15, 30, 45, 60, 90, 120, and 180 min after the glucose load. Plasma glucose levels were analyzed at the RCPH using a glucose oxidase method (17). Serum insulin was analyzed at Steno Diabetes Center (14). The IVGTT was performed at Steno Diabetes Center by the protocol described above (13).

Anthropometric measurements
Body weight (with light clothing) was measured to the nearest 0.1 kg and height (without shoes) was estimated to the nearest 0.5 cm. BMI was calculated as weight in kilograms divided by the square of height in meters. Waist circumference (to the nearest centimeter, individuals without clothes) was measured midway between the lowest rib and the iliac crest on standing subjects. Hip circumference (to the nearest centimeter with individuals in underwear) was measured over the widest part of the gluteal region. Fat mass was measured using a bioelectrical impedance method (18).

Statistical methods
An empirical data-driven approach was chosen, using multiple linear regression to derive predictive equations of log(SI) and log(AIR), i.e., the natural logarithm. Demographic data and glucose and insulin concentrations during the OGTT were used as independent variables in the analysis. To adjust for within-family correlation, a random family factor was added to the models. An a priori analysis strategy was formulated to ensure efficient exploitation of the data. The models were based on untransformed and transformed glucose and insulin results (square and reciprocal transformation) and standardized areas under the concentration curves for plasma glucose and serum insulin, defined as the area under the curve, above baseline from time 0 to time t minutes divided by t. The demographic factors included age, sex, height, body weight, waist circumference, hip circumference, fat mass, BMI, waist-to-hip ratio, and fat mass-to-body weight ratio.

Of the total data, ~75% were randomized (stratified according to age and missing data status) to an estimation sample used for predicting log(SI) and log(AIR). The remaining 25% of the data were considered as an internal validation sample for assessment of the accuracy of the predictive equations, i.e., a cross validation. Furthermore, external validation was provided by the application of the predictive models to the data from the RCPH.

A combination of backwards elimination and forward selection was chosen in the modeling phase to handle the large number of variables in each model. A model was initially based on plasma glucose and serum insulin levels at 0, 30, 60, 90, 120, and 180 min as regression variables to describe the established indexes of insulin sensitivity and ß-cell function. Depending on which of these variables was statistically significant at a 10% significance level, values at adjacent time points were added sequentially to the model. We have thus used plasma glucose and serum insulin responses from several time points during the OGTT to generate the optimal equations for OGTT-derived indexes of insulin sensitivity (BIGTT-SI|full) and ß-cell function (BIGTT-AIRfull). Also, we generated and tested simple indexes of SI and AIR using time points that are routinely measured in most metabolic, genetic, and epidemiological studies, i.e., at 0, 30, and 120 min (BIGTT-SI|0-30-120 and BIGTT-AIR0-30-120), and 0, 60, and 120 min (BIGTT-SI|0-60-120 and BIGTT-AIR0-60-120), respectively.

Evaluations and comparisons between models were based on the residual SD and the correlation coefficient (R2) obtained from the regressions. R2 describes the degree of variation explained by the model relative to the total variation in the population subjected to analysis. Because R2 is population dependent, it can only be used for comparisons of models within a dataset, not between datasets. However, the SD is comparable between models applied to various datasets, as the SD on the log scale corresponds approximately to the coefficient of variation of the predicted SI and AIR on the original scale.

Calculations of insulin sensitivity and acute insulin response using previously published models
Formulas from previously published models were applied to the present datasets to compare the accuracy of the different models (Table 3). As previously described models were not based on log-transformed measures of insulin sensitivity and ß-cell function, the accuracy has been assessed after performance of an adjustment based on a regression analysis of the log-transformed result of each formula, measuring concordance with the log(SI) and log(AIR) estimating an intercept based on the estimation dataset. Thus, the risk of performing an unfair comparison with the BIGTT models is eliminated, because additional corrections to the data are obtained by the adjustment.


View this table:
[in this window]
[in a new window]

  		Table 3— SD and R2 for various indices of the SI compared with the SI as estimated from an IVGTT and indices of ß-cell function compared with AIR as calculated from an IVGTT

 

   RESULTS—
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS--
CONCLUSIONS--
 References
 
Characteristics of participants are given in Table 1. Table 2 shows the predictive equations that were generated for calculations of BIGTT-SI and BIGTT-AIR. Estimates of SI (BIGTT-SI|full) and AIR (BIGTT-AIRfull) were highly correlated to IVGTT-derived values of SI (R2 = 0.77) and AIR (R2 = 0.54) (Table 3).


View this table:
[in this window]
[in a new window]

  		Table 1— Clinical and biochemical data for 258 nondiabetic individuals without IGT used for model development and internal validation and for 28 nondiabetic individuals without IGT for external validation

 

View this table:
[in this window]
[in a new window]

  		Table 2— OGTT-derived models for calculations of SI and AIR in nondiabetic individuals without IGT

 
Each of the OGTT-derived estimates of SI was compared to estimates of SI obtained in the internal and external validation dataset as well as to estimates of insulin sensitivity using the fasting insulin level, the homeostasis model assessment (HOMA), and four other previously published models (Table 3). On the basis of the SD of the estimates, both the full model (BIGTT-SI|full) and the two more simple models (BIGTT-SI|0-30-120 and BIGTT-SI|0-60-120) for estimation of SI had an ~30% higher accuracy than two widely used simple indexes of insulin sensitivity, i.e., fasting insulin and HOMA (Table 3). The OGTT-derived estimates of SI were almost similar in the two validation datasets (Table 3). The relationship between SI obtained from the IVGTT and BIGTT-SI|0-60-120 is presented in Fig. 1A, which shows a high degree of correlation at all levels of insulin sensitivity. A similar correlation at all levels of insulin sensitivity is seen by applying the optimal model (BIGTT-SI|full) as well as the BIGTT-SI|0-30-120 (data not shown).


Figure 1
View larger version (15K):
[in this window]
[in a new window]

  		Figure 1— A: Relationship between SI obtained from an IVGTT [known log(SI)] and SI obtained from OGTT-based data from plasma glucose and serum insulin levels at t = 0, 60, and 120 min; sex; and BMI [predicted log (BIGTT-SI|0-60-120)]. Triangles depict data from the estimation sample; circles and squares depict data from the internal and external validation samples, respectively. B: Relationship between serum AIR during 0–8 min obtained from an IVGTT [known log(AIR)] and AIR obtained from OGTT-based data using information from plasma glucose and serum insulin levels at t = 0, 60, and 120 min; sex; and BMI [predicted log(BIGTT-AIR0-60-120)]. Triangles depict data from the estimation sample; circles and squares depict data from the internal and external validation samples, respectively.

 
The SD and R2 for various indexes of ß-cell function are also shown in Table 3. The novel BIGTT-AIR methods are about 20–30% more accurate than three currently used models for estimation of ß-cell function, and the estimates were very similar in the two validation datasets (Table 3). The relationship between ß-cell function estimated by the IVGTT and by the BIGTT-AIR0-60-120 is shown in Fig. 1B.

For subjects with IGT, the BIGTT models for the estimation of indexes of insulin sensitivity and ß-cell function were less accurate than when they were applied to data from nondiabetic individuals without IGT (see Table 1 of the online appendix available at http://dx.doi.org/10.2337/dc06-1240). This was a general observation for all applied models. However, the Matsuda, Cederholm, and Belfiori indexes did seem to capture the insulin sensitivity for subjects with IGT in a more satisfactory manner than the BIGTT model. Regarding the indexes of ß-cell function, the BIGTT model was more accurate than the alternative models (see Table 1 of the online appendix).


   CONCLUSIONS—
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS--
 CONCLUSIONS--
References
 
We present novel and validated models for calculation of SI and AIR with data available from an OGTT. The models are developed for accurate measurement of SI and AIR in nondiabetic individuals without IGT. The plasma glucose level obtained at 120 min after the ingestion of the glucose load identifies individuals for whom the method is applicable and at the same time identifies individuals having IGT or overt diabetes. Patients with type 2 diabetes and IGT are characterized by various degrees of abnormalities in both insulin action and insulin secretion (19), and it is therefore unlikely that models for measurements of insulin sensitivity and ß-cell function derived from an OGTT could be accurate throughout the whole spectrum of glucose tolerance (20). As expected, our model did not work as well in individuals with IGT (see Table 1 of the online appendix). If detailed information on ß-cell function and/or insulin sensitivity is essential in these individuals, other methods have to be used in addition to the OGTT. All three BIGTT-SI models were highly positively correlated (R2 = 0.69–0.77) to the SI derived from an IVGTT. This was the case for both the estimation dataset and the validation datasets. As correlation coefficients should not be used for comparisons between studies, we also report the residual SD of log(SI) for the various models derived from the present dataset. We find that all of our three models provide more accurate estimates of insulin sensitivity than various previously published methods (7–12). The higher accuracy of the present models might be due to 1) the fact that the models were developed using detailed data from a relatively large study population (n = 194), 2) only data from nondiabetic individuals without IGT were used for model development to avoid the confounding effect of overt hyperglycemia on estimates of insulin secretion and action, and 3) the fact that information on sex and BMI were included. It is noteworthy that for log(SI) the estimated parameters for sex and BMI show a high degree of consistency among the different models, indicating that adjustment for these factors is indeed relevant. However, adding information about sex and BMI to previously used indexes did not improve their accuracy.

In the present study we have chosen to use insulin sensitivity estimates from a frequently sampled IVGTT as reference for the BIGTT-SI models. Most other published OGTT-derived models for estimation of insulin sensitivity are developed on the basis of data from euglycemic-hyperinsulinemic clamp studies. We believe, however, that our models provide an estimate of insulin sensitivity that could be compared with clamp data, as previous reports have shown a strong positive correlation between SI obtained from the frequently sampled IVGTT and SI obtained from the euglycemic-hyperinsulinemic clamp in normoglycemic individuals (5,21).

The models derived from OGTT data for measurement of ß-cell function were developed with the AIR0–8 min response from the IVGTT, which is the gold standard, as reference. The models are highly accurate compared with other available methods using OGTT data for calculation of insulin secretion (Table 3) (9,12,22–26). Both our models and other models for measurement of ß-cell function were less accurate when applied to individuals with IGT, but the BIGTT model was still more accurate than the alternative models (see Table 1 of the online appendix). Adding information on sex, height, and weight to previously used indexes did not improve their accuracy.

In contrast to anthropometric variables, which are reproducible among laboratories, assay characteristics for measurement of serum insulin such as linearity, recovery, accuracy, precision, and cross-reactivity to proinsulin and its primary conversion intermediates vary among laboratories (27). In the present model we have used an insulin assay with no cross-reactivity to proinsulin and its primary conversion intermediates (14). Whether our model is valid when serum insulin levels are analyzed by other assays remains to be studied.

In summary, we have developed and validated novel models for assessment of OGTT-derived estimates of SI and AIR. Information on sex and BMI combined with analysis of plasma glucose and serum insulin levels in the fasting state and up to eight time points during 4 h (full models) provides indexes for SI and AIR that are highly correlated to indexes obtained from a frequently sampled IVGTT. Furthermore, we have validated more simple OGTT-based models that can be used to predict estimates of SI and AIR, incorporating information on sex, BMI, and measurement of plasma glucose and serum insulin levels at 0, 30, 60, and 120 min. The models are designed for nondiabetic individuals without IGT; glucose tolerance is also being estimated from the OGTT. Because of the simplicity of these models, they can be implemented in large scale metabolic, genetic, and epidemiological studies.


   Acknowledgments
 
This study was supported by grants from the Danish Medical Research Council, the European Union (BMH4-CT98-3084 and QLK-CT-200-01038), the Velux Foundation, the Danish Diabetes Association, and The Danish Heart Foundation.

We thank the participants who took part in the studies and the staff at the Steno Diabetes Center and Research Centre for Prevention and Health.


   Footnotes
 
T.H. and T.D. contributed equally to this work.

Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/dc06-1240.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

Received for publication June 15, 2006. Accepted for publication October 19, 2006.


   References
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS--
 CONCLUSIONS--
 References
 

  1. Andres R, Swerdloff T, Pozefsky T, Coleman D: Manual feedback technique for the control of blood glucose concentration. In Automation in Analytical Chemistry. Skeggs LTJ, Ed. New York, Mediad, 1966, p. 486–491
  2. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 177–269, 1997
  3. Ferrannini E, Mari A: How to measure insulin sensitivity. J Hypertens 16:895–906, 1998[Medline]
  4. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667–E677, 1979
  5. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790–800, 1987[Medline]
  6. Hollenbeck CB, Chen N, Chen YD, Reaven GM: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33:460–463, 1984[Abstract]
  7. Belfiore F, Iannello S, Volpicelli G: Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63:134–141, 1998[Medline]
  8. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470, 1999[Abstract/Free Full Text]
  9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985[Medline]
  10. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301, 2000[Abstract]
  11. Cederholm J, Wibell L: Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167–175, 1990[Medline]
  12. Wareham NJ, Phillips DI, Byrne CD, Hales CN: The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931, 1995[Medline]
  13. Hansen T, Ambye L, Grarup N, Hansen L, Echwald SM, Ferrer J, Pedersen O: Genetic variability of the SUR1 promoter in relation to ß-cell function and type II diabetes mellitus. Diabetologia 44:1330–1334, 2001[Medline]
  14. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME: Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578–582, 1993[Abstract/Free Full Text]
  15. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113–122, 1986[Medline]
  16. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K: Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 18:126–132, 2001[Medline]
  17. Kadish AH, Little RL, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116–131, 1968
  18. Heitmann BL: Prediction of body water and fat in adult Danes from measurement of electrical impedance: a validation study. Int J Obes 14:789–802, 1990[Medline]
  19. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959–965, 1993[Abstract/Free Full Text]
  20. Groop LC, Widen E, Ferrannini E: Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36:1326–1331, 1993[Medline]
  21. Beard JC, Bergman RN, Ward WK, Porte DJ: The insulin sensitivity index in nondiabetic man: correlation between clamp-derived and IVGTT-derived values. Diabetes 35:362–369, 1986[Abstract]
  22. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26:44–49, 1984[Medline]
  23. Byrne CD, Wareham NJ, Brown DC, Clark PM, Cox LJ, Day NE, Palmer CR, Wang TW, Williams DR, Hales CN: Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 37:889–896, 1994[Medline]
  24. Efendic S, Luft R, Wajngot A: Aspects of the pathogenesis of type 2 diabetes. Endocr Rev 5:395–410, 1984[Medline]
  25. Kosaka K, Hagura R, Kuzuya T: Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26:944–952, 1977[Medline]
  26. Phillips DI, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286–292, 1994[Medline]
  27. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Report of the American Diabetes Association’s Task Force on standardization of the insulin assay. Diabetes 45:242–256, 1996[Abstract]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
N. Grarup, G. Andersen, N. T. Krarup, A. Albrechtsen, O. Schmitz, T. Jorgensen, K. Borch-Johnsen, T. Hansen, and O. Pedersen
Association Testing of Novel Type 2 Diabetes Risk Alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With Insulin Release, Insulin Sensitivity, and Obesity in a Population-Based Sample of 4,516 Glucose-Tolerant Middle-Aged Danes
Diabetes, September 1, 2008; 57(9): 2534 - 2540.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Grarup, K. L. Stender-Petersen, E. A. Andersson, T. Jorgensen, K. Borch-Johnsen, A. Sandbaek, T. Lauritzen, O. Schmitz, T. Hansen, and O. Pedersen
Association of Variants in the Sterol Regulatory Element-Binding Factor 1 (SREBF1) Gene With Type 2 Diabetes, Glycemia, and Insulin Resistance: A Study of 15,734 Danish Subjects
Diabetes, April 1, 2008; 57(4): 1136 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. H. Andreasen, K. L. Stender-Petersen, M. S. Mogensen, S. S. Torekov, L. Wegner, G. Andersen, A. L. Nielsen, A. Albrechtsen, K. Borch-Johnsen, S. S. Rasmussen, et al.
Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation
Diabetes, January 1, 2008; 57(1): 95 - 101.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Grarup, C. S. Rose, E. A. Andersson, G. Andersen, A. L. Nielsen, A. Albrechtsen, J. O. Clausen, S. S. Rasmussen, T. Jorgensen, A. Sandbaek, et al.
Studies of Association of Variants Near the HHEX, CDKN2A/B, and IGF2BP2 Genes With Type 2 Diabetes and Impaired Insulin Release in 10,705 Danish Subjects: Validation and Extension of Genome-Wide Association Studies
Diabetes, December 1, 2007; 56(12): 3105 - 3111.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansen, T.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, T.
Right arrow Articles by Pedersen, O.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum